NCT06226129View on ClinicalTrials.gov

Gadopiclenol in Contrast Enhanced MRI of the Prostate

PHASE4RecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

February 14, 2024

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2028

Conditions

Prostate Cancer

Interventions

DRUG

Gadopiclenol

Gadopiclenol for contrast enhanced MRI

Trial Locations (1)

10032

RECRUITING

Columbia University Medical Center, New York

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Guerbet

INDUSTRY

lead

Columbia University

OTHER

NCT06226129 - Gadopiclenol in Contrast Enhanced MRI of the Prostate | Biotech Hunter | Biotech Hunter